Physician profile
Amit Mehta
NPI 1407823834
$7,930.33
in general payments reported to CMS, 2019-2025
11 companies · $1,148 in 2025
The $1,148 reported for 2025 was more than what 86% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $13.27 · 2021: $19.93 · 2022: $177 · 2023: $975 · 2024: $5,440 · 2025: $1,148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,350 · Food and Beverage: $212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,350.00 |
| Food and Beverage | $212.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $3,450.00 | 2024 | |
| Sentynl Therapeutics, INC. | $2,925.00 | 2024-2025 | |
| Becton, Dickinson and Company | $975.00 | 2023 | |
| Sirtex Medical INC | $172.65 | 2025 | Lava Les (Liquid Embolic System) |
| Boston Scientific Corporation | $138.76 | 2019 | |
| Angiodynamics, INC. | $125.00 | 2022 | |
| Penumbra, INC. | $51.54 | 2022 | |
| Mozarc Medical US LLC | $39.54 | 2024 | Palindrome |
| Cook Medical LLC | $19.93 | 2021 | |
| Ekos Corporation | $19.64 | 2019 | |
| Medtronic USA, INC. | $13.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.